Australian scientists develop a blood test that can “dramatically improve” early detection of the disease
The blood test still has to undergo further testing before it is made available to the public. Credit: Getty Images
Ovarian cancer, a disease that kills around 150,000 women in the world every year, can now be caught early. A new blood test developed by Australian scientists using a bacterial toxin first discovered in Adelaide has the potential to "dramatically improve" the detection of the disease.
Scientists from the University of Adelaide and Griffith University, who have published their study in the journal Biochemical and Biophysical Research Communications, have found this after studying the interactions between the toxin and an abnormal glycan (sugar) expressed on the surface of human cancer cells and released into the blood.
They were then able to engineer a portion of the two to detect glycans in blood samples of women suffering with ovarian cancer. The blood test has to undergo further tests before it is made publicly available.
During the research, the scientists could detect significant levels of the cancer glycan in blood samples from over 90 per cent of the women with stage 1 ovarian cancer they tested using the test they had developed. This is when seven out of 10 women with this cancer are diagnosed at later stages.
Professor James Paton, Director of the University of Adelaide's Research Centre for Infectious Diseases, was reported as saying, “Ovarian cancer is notoriously difficult to detect in its early stages, when there are more options for treatment and survival rates are better. Our new test is therefore a potential game changer.”
We are a voice to you; you have been a support to us. Together we build journalism that is independent, credible and fearless. You can further help us by making a donation. This will mean a lot for our ability to bring you news, perspectives and analysis from the ground so that we can make change together.